TD Cowen analyst Marc Frahm raised the price target on Theravance Biopharma (NASDAQ: TBPH) to $15.00 (from $13.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE